Updated Analysis Of A Phase I Trial Of Afatinib (Afa) And Bevacizumab (Bev) In Chemo-Naive Patients (Pts) With Advanced Non-Small Cell Lung Cancer (Nsclc) Harboring Egfr-Mutations: Olcsg1404

T. Ninomiya,N. Nogami, T. Kozuki, D. Harada,T. Kubo, K. Ohashi,S. Kuyama,K. Kudo, A. Bessho,N. Fujimoto, K. Aoe, T. Shibayama, D. Minami,K. Sugimoto, N. Ochi,N. Takigawa, K. Hotta, K. Kiura

ANNALS OF ONCOLOGY(2019)

引用 1|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要